Assessing Trans-Inhibition of OATP1B1 and OATP1B3 by Calcineurin and/or PPIase Inhibitors and Global Identification of OATP1B1/3-Associated Proteins.
Assessing Trans-Inhibition of OATP1B1 and OATP1B3 by Calcineurin and/or PPIase Inhibitors and Global Identification of OATP1B1/3-Associated Proteins.
复制标题
DOI:
10.3390/pharmaceutics16010063
复制
发表时间:
2023-12-31
期刊:
影响因子:
5.4
通讯作者:
Yue W
中科院分区:
文献类型:
--
作者:
Powell JT;Kayesh R;Ballesteros-Perez A;Alam K;Niyonshuti P;Soderblom EJ;Ding K;Xu C;Yue W
Organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 are key determinants of drug–drug interactions (DDIs). Various drugs including the calcineurin inhibitor (CNI) cyclosporine A (CsA) exert preincubation-induced trans-inhibitory effects upon OATP1B1 and/or OATP1B3 (abbreviated as OATP1B1/3) by unknown mechanism(s). OATP1B1/3 are phosphoproteins; calcineurin, which dephosphorylates and regulates numerous phosphoproteins, has not previously been investigated in the context of preincubation-induced trans-inhibition of OATP1B1/3. Herein, we compare the trans-inhibitory effects exerted on OATP1B1 and OATP1B3 by CsA, the non-analogous CNI tacrolimus, and the non-CNI CsA analogue SCY-635 in transporter-overexpressing human embryonic kidney (HEK) 293 stable cell lines. Preincubation (10–60 min) with tacrolimus (1–10 µM) rapidly and significantly reduces OATP1B1- and OATP1B3-mediated transport up to 0.18 ± 0.03- and 0.20 ± 0.02-fold compared to the control, respectively. Both CsA and SCY-635 can trans-inhibit OATP1B1, with the inhibitory effects progressively increasing over a 60 min preincubation time. At each equivalent preincubation time, CsA has greater trans-inhibitory effects toward OATP1B1 than SCY-635. Preincubation with SCY-635 for 60 min yielded IC50 of 2.2 ± 1.4 µM against OATP1B1, which is ~18 fold greater than that of CsA (0.12 ± 0.04 µM). Furthermore, a proteomics-based screening for protein interactors was used to examine possible proteins and processes contributing to OATP1B1/3 regulation and preincubation-induced inhibition by CNIs and other drugs. A total of 861 and 357 proteins were identified as specifically associated with OATP1B1 and OATP1B3, respectively, including various protein kinases, ubiquitin-related enzymes, the tacrolimus (FK506)-binding proteins FKBP5 and FKBP8, and several known regulatory targets of calcineurin. The current study reports several novel findings that expand our understanding of impaired OATP1B1/3 function; these include preincubation-induced trans-inhibition of OATP1B1/3 by the CNI tacrolimus, greater preincubation-induced inhibition by CsA compared to its non-CNI analogue SCY-635, and association of OATP1B1/3 with various proteins relevant to established and candidate OATP1B1/3 regulatory processes.
登录
查看更多内容
影响因子:
2.9
作者:
Daum, Sebastian;Schumann, Michael;Mathea, Sebastian;Aumueller, Tobias;Balsley, Molly A.;Constant, Stephanie L.;de Lacroix, Boris Feaux;Kruska, Fabian;Braun, Manfred;Schiene-Fischer, Cordelia
通讯作者:
Schiene-Fischer, Cordelia
影响因子:
3.7
作者:
Crowe A;Zheng W;Miller J;Pahwa S;Alam K;Fung KM;Rubin E;Yin F;Ding K;Yue W
通讯作者:
Yue W
影响因子:
7.3
作者:
Fu, Jiping;Tjandra, Meiliana;Sweeney, Zachary K.
通讯作者:
Sweeney, Zachary K.
影响因子:
32.4
作者:
Colgan, J;Asmal, M;Luban, J
通讯作者:
Luban, J
影响因子:
3.8
作者:
Farasyn, Taleah;Crowe, Alexandra;Yue, Wei
通讯作者:
Yue, Wei